19 results
425
SLXN
Biomotion Sciences Ordinary Shares
25 Jul 24
Business combination disclosure
4:05pm
run - in Phase 2 expanded Phase 3 21 World - Renowned Expert Scientific Advisory Board Eileen M. O'Reilly, MD Memorial Sloan Kettering, NY, NY
425
MACA
Moringa Acquisition Corp
25 Jul 24
Business combination disclosure
4:05pm
World - Renowned Expert Scientific Advisory Board Eileen M. O'Reilly, MD Memorial Sloan Kettering, NY, NY Winthrop Rockefeller Endowed Chair
DEFM14A
MACA
Moringa Acquisition Corp
17 Jul 24
Proxy related to merger
9:13am
. Brachfeld qualifies as an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management
PRE 14A
8941 j4n5
15 Dec 22
Preliminary proxy
5:18pm
10-K
llsjcrm1jgjolzydtsdv
31 Mar 21
Annual report
5:15pm
8-K
EX-10.7
h43jo fuh1
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.9
qn01qubzsk osbw
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.11
sfesmlxat7qdzdgf
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.8
kzaxn7my7ywbpz hjhn
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.12
wx8un45yh i5
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.6
hpj17ziqih t2vbn
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.10
v2oukq2zo447pzx9 ld
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
424B4
wr2asdya94mepcbn9d
17 Feb 21
Prospectus supplement with pricing info
11:53am
S-1
EX-10.7
7100a55hds vw
1 Feb 21
IPO registration
4:12pm
S-1
57lh4hzc11d7
1 Feb 21
IPO registration
4:12pm
DRS
5fgeatbf
22 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next